Delay was apparently was evidence-based. I had thought otherwise at 1st; thought they did not have enough doses. But the mix and matching was just seemed like a random circumstance and even more interesting as a result.
-
This Tweet is unavailable.
-
-
Replying to @BiellaColeman @asociologist
Mixing-and-matching same type vaccines regardless of brand is standard guidance for other vaccines (they'll try to stick to brand but if not, standard practice to use other brand). The doses are different but vaccines aren't drugs so less of an issue, if at all, for boosters.
1 reply 0 retweets 2 likes -
Heterologous boost — mixing & matching different types — is different. From day one, I heard from the people in the field that they expected it to *work better* and turns out that's what happened. "Follow the Science" shouting on Twitter/media isn't a true overlap with expertise.
1 reply 0 retweets 2 likes
I think "impure" science has an overlap, but I'd call it performative/poor science for the new public sphere tbh. (For the more straightforward stuff that got fed into the controversy mill, I mean: not that there was no uncertainty, but it wasn't some major epistemic crisis).
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.